ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Atlanta, GA, USA:

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (Pembro/IORT)

Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatme ...

Enrolling
Triple Negative Breast Cancer
Drug: Merck 3475 Pembrolizumab
Radiation: Intraoperative radiation therapy (IORT)

Phase 1

Eileen Connolly

Atlanta, Georgia, United States and 2 other locations

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...

Enrolling
Breast Cancer
Drug: Talazoparib

Phase 2

Mass General Brigham
Mass General Brigham

Atlanta, Georgia, United States and 6 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Enrolling
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Atlanta, Georgia, United States and 27 other locations

A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Rec ...

Enrolling
Breast Cancer
Drug: Adjuvant Therapy
Drug: Palbociclib

Phase 2

Criterium

Atlanta, Georgia, United States and 14 other locations

breast biopsy occurs if biopsy is needed....

Enrolling
Breast Cancer
Device: Digital Mammography
Device: CBBCT Imaging
Koning Health

Dacula, Georgia, United States and 3 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Atlanta, Georgia, United States and 32 other locations

OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...

Enrolling
Breast Cancer
Drug: RGT-419B
Drug: RGT-419B in combination with hormonal therapy

Phase 1

Regor Pharmaceuticals

Atlanta, Georgia, United States and 4 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Atlanta, Georgia, United States and 62 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Atlanta, Georgia, United States and 117 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Atlanta, Georgia, United States and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems